Browsing by Subject "435/325"

Now showing items 1-7 of 7

    • Cancer treatment targeting non-coding RNA overexpression 
      Safe, Stephen; Kim, Kyounghyun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)
      Provided herein are methods directed to modulating the pro-oncogenic effects of noncoding RNAs (ncRNAs) through their interactions with specificity protein transcription factors (SpTFs). In one aspect, the disclosure ...
    • Cells and methods for the generation of transgenic pigs 
      Piedrahita, Jorge A.; Bazer, Fuller W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-08-07)
      Disclosed are methods for the isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell ...
    • Compositions and methods related to toll-like receptor-3 
      Kao, Cheng C.; Tharachaparamba, Ranjith Kumar (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-11-29)
      The invention relates to compositions and methods related to Toll-like receptor (TLR) polypeptides. In some embodiments, the invention relates to managing TLR3 related diseases. In further embodiments, the invention relates ...
    • DbpA compositions and methods of use 
      Guo, Betty P.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-11-06)
      Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
    • DNA encoding Actinobacillus pleuropneumoniae hemolysin 
      Struck, Douglas K.; Young, Ryland F.; Chang, Yung-Fu (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1997-06-24)
      This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides ...
    • Methods comprising apoptosis inhibitors for the generation of transgenic pigs 
      Piedrahita, Jorge A.; Bazer, Fuller W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2002-04-09)
      Disclosed are methods for the isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell ...
    • Polypeptides and polynucleotides from coagulase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacy; Ni Eidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2003-10-21)
      Isolated proteins, designated SdrF, SdrG and SdrH, and their corresponding amino acid and nucleic acid sequences are provided which are useful in the prevention and treatment of infection caused by coagulase-negative ...